Browsing Category
Pharma Industry News
4741 posts
Business-News-Today.com section for global pharma industry news, Indian pharma sector latest news, pharma sector news today, pharmaceuticals industry news.
Artemis acquires Millrock Technology to expand lyophilization innovation in life sciences
Artemis Capital Partners acquires Millrock Technology to scale lyophilization systems, fueling growth in biologics, vaccines, and diagnostics innovation.
Made Scientific and Syenex team up to reshape T cell therapy manufacturing with advanced bioengineering platforms
Made Scientific and Syenex partner to scale T cell therapy manufacturing with UltraCell and RapidCell systems, aiming to cut costs and speed timelines.
Are AI-discovered vaccines the next big frontier in pharma?
AI-discovered vaccines are moving from hype to reality. See how Evaxion, BioNTech, DIOSynVax and Baseimmune are reshaping discovery—and why big pharma is buying.
Klotho Neurosciences expands beyond the anti-aging gene with Turn Biotechnologies acquisition plan
Klotho Neurosciences moves to buy Turn Bio’s ERA and eTurna assets plus a $300M Korea pharma deal. Explore how this could reshape its longevity pipeline.
Can the Barinthus–Clywedog merger reshape diabetes and autoimmune drug pipelines?
Barinthus Biotherapeutics merges with Clywedog Therapeutics in an all-stock deal. Explore the impact on diabetes, celiac drug pipelines, and BRNS stock.
Vaxcyte’s $1bn Thermo Fisher deal: Can new U.S. vaccine capacity secure its PCV future?
Vaxcyte partners with Thermo Fisher in a $1B deal to build U.S. fill-finish vaccine capacity. Find out why this matters for its PCV pipeline and investors.
Sanofi taps Novavax’s Matrix-M for flu: Is NVAX stock finally turning a corner?
Novavax (NASDAQ: NVAX) expands Sanofi partnership, granting rights to Matrix-M adjuvant for pandemic flu candidates. See stock impact and outlook.
Why Tilray’s new high-THC cannabis products in Germany could shift its European strategy
Tilray expands its German medical cannabis portfolio with five new EU-GMP craft strains. Find out how this bold move could reshape its European strategy.
What Sutro Biopharma’s restructuring says about biotech layoffs and investor sentiment in 2025
Sutro Biopharma (NASDAQ: STRO) slashes jobs and narrows its pipeline to extend cash runway into 2027. What does this restructuring mean for investors?
How AnaptysBio’s 2026 spin-off plan could reshape its pipeline, royalty flows, and stock outlook
Discover how AnaptysBio (NASDAQ: ANAB) plans to split into two focused companies to unlock hidden value and reshape its investment story.